Form 4: HealthEquity Founder and Vice Chairman Reports Routine Stock Disposition for Tax Obligations

Stephen Neeleman, Founder and Vice Chairman of HealthEquity, Inc., reported the disposition of 1,049 shares of common stock to cover tax withholding obligations at a price of $100.8721 per share.

Summary

• Stephen Neeleman, a Director and Officer (Founder and Vice Chairman) of HealthEquity, Inc. (HQY), reported a change in his beneficial ownership.
• On July 3, 2025, Neeleman disposed of 1,049 shares of HealthEquity Common Stock.
• This disposition was made at a price of $100.8721 per share.
• The transaction code 'F' indicates that these shares were disposed of to cover tax withholding obligations.
• Following this transaction, Neeleman directly beneficially owns 112,593 shares of Common Stock.
• He also indirectly beneficially owns 553,235 shares through the Stephen and Christine Neeleman Trust and 203,000 shares through Neeleman Family Holdings, LLC, though he disclaims beneficial ownership of the latter except to the extent of his pecuniary interest.
• Neeleman also holds various stock options: 19,897 shares with an exercise price of $41.28 expiring on March 27, 2027; 14,228 shares with an exercise price of $61.72 expiring on March 27, 2028; and 15,337 shares with an exercise price of $73.61 expiring on March 26, 2029. All these options are immediately exercisable.

Sentiment

Score: 6

Explanation: The transaction is a routine, non-discretionary disposition for tax purposes, which is neutral in sentiment. The continued significant beneficial ownership and stock options held by a key executive are mildly positive, indicating ongoing alignment.

Positives

• The transaction is a non-discretionary disposition for tax withholding, which is a routine event for insiders receiving equity compensation and does not reflect a discretionary sale.
• Stephen Neeleman retains significant direct and indirect beneficial ownership in HealthEquity, totaling 868,828 shares (112,593 direct + 553,235 indirect + 203,000 indirect), indicating continued alignment with shareholder interests.
• The existence of substantial stock options with various exercise prices suggests ongoing equity incentives for a key executive, reinforcing long-term commitment.

Negatives

• A disposition of shares, even for tax purposes, results in a slight reduction in the insider's direct ownership.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic outlook, as its purpose is solely to report insider transactions.

Industry Context

This Form 4 filing is a routine insider transaction report and does not provide information directly related to broader industry trends or competitive dynamics within the healthcare financial services sector. It reflects an individual executive's equity compensation management.

Comparison to Industry Standards

• This Form 4 filing is a standard disclosure of an insider transaction for tax withholding purposes. Such transactions are common across all industries for executives receiving equity compensation and do not typically lend themselves to direct comparison with specific company or project results.
• The disposition of shares to cover tax obligations is a routine and expected event when equity awards vest, aligning with common corporate compensation practices.

Stakeholder Impact

• Shareholders: The transaction is a routine tax-related disposition by a key insider, which is generally not indicative of a change in company fundamentals or a lack of confidence. The insider retains substantial ownership, aligning interests.
• Employees: No direct impact on employees is indicated by this insider transaction report.
• Customers: No direct impact on customers is indicated by this insider transaction report.
• Suppliers: No direct impact on suppliers is indicated by this insider transaction report.
• Creditors: No direct impact on creditors is indicated by this insider transaction report.

Key Dates

Recommendation

Keywords

HealthEquity, HQY, Stephen Neeleman, SEC Form 4, Insider Transaction, Stock Disposition, Tax Withholding, Beneficial Ownership, Stock Options, Corporate Governance